Clinical Trial Update: Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT [Phase 4]

View source ↗

Summary

A Phase 4 cluster randomized trial is evaluating a smallpox vaccine for post-exposure prophylaxis in mpox (monkeypox) exposures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• Smallpox vaccine (Mpox post-exposure prophylaxis) (Modified Vaccinia Ankara-based smallpox vaccine)

Snippet

Sponsor: McMaster University | Conditions: Monkeypox | Phase 4 | Status: RECRUITING